These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 17661457

  • 1. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
    Iyer M, Hopfinger AJ.
    J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
    [Abstract] [Full Text] [Related]

  • 2. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
    Yuan H, Parrill A.
    J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
    [Abstract] [Full Text] [Related]

  • 3. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT, Roy K.
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH, Zhang XY, Tan JJ, Chen WZ, Wang CX.
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
    Nunthaboot N, Tonmunphean S, Parasuk V, Wolschann P, Kokpol S.
    Eur J Med Chem; 2006 Dec; 41(12):1359-72. PubMed ID: 17002889
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. QSAR studies of HIV-1 integrase inhibition.
    Yuan H, Parrill AL.
    Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870
    [Abstract] [Full Text] [Related]

  • 11. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8430-45. PubMed ID: 17010623
    [Abstract] [Full Text] [Related]

  • 12. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
    Ravichandran V, Shalini S, Sundram K, Sokkalingam AD.
    Eur J Med Chem; 2010 Jul 15; 45(7):2791-7. PubMed ID: 20347187
    [Abstract] [Full Text] [Related]

  • 13. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
    Cheng Z, Zhang Y, Fu W.
    Eur J Med Chem; 2010 Sep 15; 45(9):3970-80. PubMed ID: 20561721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Zhao H, Burke TR, Pommier Y, Milne GW.
    J Med Chem; 1997 Mar 14; 40(6):930-6. PubMed ID: 9083481
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.